213 related articles for article (PubMed ID: 33844153)
21. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
22. High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis.
Oxombre B; Lee-Chang C; Duhamel A; Toussaint M; Giroux M; Donnier-Maréchal M; Carato P; Lefranc D; Zéphir H; Prin L; Melnyk P; Vermersch P
Br J Pharmacol; 2015 Apr; 172(7):1769-82. PubMed ID: 25521311
[TBL] [Abstract][Full Text] [Related]
23.
Chen BY; Ghezzi C; Villegas B; Quon A; Radu CG; Witte ON; Clark PM
J Nucl Med; 2020 May; 61(5):757-763. PubMed ID: 31653711
[TBL] [Abstract][Full Text] [Related]
24. Absence of system x
Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
[TBL] [Abstract][Full Text] [Related]
25. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
26. Naringenin attenuates experimental autoimmune encephalomyelitis by protecting the intact of blood-brain barrier and controlling inflammatory cell migration.
Niu X; Sang H; Wang J
J Nutr Biochem; 2021 Mar; 89():108560. PubMed ID: 33249188
[TBL] [Abstract][Full Text] [Related]
27. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE).
Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaei M; Keyvani H
Int Immunopharmacol; 2020 Jan; 78():105943. PubMed ID: 31830622
[TBL] [Abstract][Full Text] [Related]
29. Eosinophils are dispensable for development of MOG
Ruppova K; Lim JH; Fodelianaki G; August A; Neuwirth A
Immunol Lett; 2021 Nov; 239():72-76. PubMed ID: 34499922
[TBL] [Abstract][Full Text] [Related]
30. The iNOS Activity During an Immune Response Controls the CNS Pathology in Experimental Autoimmune Encephalomyelitis.
Sonar SA; Lal G
Front Immunol; 2019; 10():710. PubMed ID: 31019516
[TBL] [Abstract][Full Text] [Related]
31. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.
Mondal S; Pahan K
PLoS One; 2015; 10(1):e0116566. PubMed ID: 25569428
[TBL] [Abstract][Full Text] [Related]
32. Nobiletin attenuates inflammation via modulating proinflammatory and antiinflammatory cytokine expressions in an autoimmune encephalomyelitis mouse model.
Yarim GF; Yarim M; Sozmen M; Gokceoglu A; Ertekin A; Kabak YB; Karaca E
Fitoterapia; 2022 Jan; 156():105099. PubMed ID: 34896483
[TBL] [Abstract][Full Text] [Related]
33. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
34. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
Lees JR; Iwakura Y; Russell JH
J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270
[TBL] [Abstract][Full Text] [Related]
35. Prevention and treatment of experimental autoimmune encephalomyelitis induced mice with 1, 25-dihydroxyvitamin D
Haghmorad D; Yazdanpanah E; Jadid Tavaf M; Zargarani S; Soltanmohammadi A; Mahmoudi MB; Mahmoudi M
Neurol Res; 2019 Oct; 41(10):943-957. PubMed ID: 31402771
[TBL] [Abstract][Full Text] [Related]
36. Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice.
Peferoen LA; Breur M; van de Berg S; Peferoen-Baert R; Boddeke EH; van der Valk P; Pryce G; van Noort JM; Baker D; Amor S
Immunology; 2016 Oct; 149(2):146-56. PubMed ID: 27388634
[TBL] [Abstract][Full Text] [Related]
37. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes.
Furlan R; Brambilla E; Ruffini F; Poliani PL; Bergami A; Marconi PC; Franciotta DM; Penna G; Comi G; Adorini L; Martino G
J Immunol; 2001 Aug; 167(3):1821-9. PubMed ID: 11466408
[TBL] [Abstract][Full Text] [Related]
38. Systemic exposure to a single dose of ferucarbotran aggravates neuroinflammation in a murine model of experimental autoimmune encephalomyelitis.
Hsiao YP; Huang CH; Lin YC; Jan TR
Int J Nanomedicine; 2019; 14():1229-1240. PubMed ID: 30863056
[TBL] [Abstract][Full Text] [Related]
39. Malat1 long noncoding RNA regulates inflammation and leukocyte differentiation in experimental autoimmune encephalomyelitis.
Masoumi F; Ghorbani S; Talebi F; Branton WG; Rajaei S; Power C; Noorbakhsh F
J Neuroimmunol; 2019 Mar; 328():50-59. PubMed ID: 30583215
[TBL] [Abstract][Full Text] [Related]
40. Astaxanthin effectiveness in preventing multiple sclerosis in animal model.
Bidaran S; Ahmadi AR; Yaghmaei P; Sanati MH; Ebrahim-Habibi A
Bratisl Lek Listy; 2018; 119(3):160-166. PubMed ID: 29536745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
